Cargando…
Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe
BACKGROUND: The Framingham Risk Score is used both in the clinical setting and in health economic analyses to predict the risk for future coronary heart disease events. Based on an American population, the Framingham Risk Score has been criticised for potential overestimation of risk in European pop...
Autores principales: | Hermansson, Jonas, Kahan, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805819/ https://www.ncbi.nlm.nih.gov/pubmed/29079929 http://dx.doi.org/10.1007/s40273-017-0578-1 |
Ejemplares similares
-
Coronary age as a risk factor in the modified Framingham risk score
por: Schisterman, Enrique F, et al.
Publicado: (2004) -
Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021) -
Validity of Pneumonia Severity Assessment Scores in Africa and South Asia: A Systematic Review and Meta-Analysis
por: Al Hussain, Sarah Khalid, et al.
Publicado: (2021) -
Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe
por: Artigao-Rodenas, Luis M., et al.
Publicado: (2013) -
Comparison of original and modified Q risk 2 risk score with Framingham risk score - An Indian perspective
por: Aggarwal, Puneet, et al.
Publicado: (2021)